These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord. Ren MF, Lu CH, Han JS. Peptides; 1985; 6(6):1015-20. PubMed ID: 2871545 [Abstract] [Full Text] [Related]
10. Dynorphin: important mediator for electroacupuncture analgesia in the spinal cord of the rabbit. Han JS, Xie GX. Pain; 1984 Apr; 18(4):367-376. PubMed ID: 6145139 [Abstract] [Full Text] [Related]
12. Sites of analgesic action of dynorphin. Kaneko T, Nakazawa T, Ikeda M, Yamatsu K, Iwama T, Wada T, Satoh M, Takagi H. Life Sci; 1983 Apr; 33 Suppl 1():661-4. PubMed ID: 6141507 [Abstract] [Full Text] [Related]
13. Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors. Dean DM, Lemaire S, Livett BG. J Neurochem; 1982 Mar; 38(3):606-14. PubMed ID: 6276506 [Abstract] [Full Text] [Related]
14. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats. Tseng LF, Fujimoto JM. J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550 [Abstract] [Full Text] [Related]